Objectives The contraction of gastrointestinal (GI) smooth muscles is regulated by both Ca 2+ -dependent and Ca 2+ sensitization mechanisms. Proline-rich tyrosine kinase 2 (Pyk2) is involved in the depolarization-induced contraction of vascular smooth muscle via a Ca 2+ sensitization pathway. However, the role of Pyk2 in GI smooth muscle contraction is unclear.
Introduction
Gastric motility requires interactions between smooth muscle, enteric and extrinsic autonomic nerves, and the intestinal cells of Cajal (ICC) (Grover, Farrugia et al. 2011) . Smooth muscle cells (SMCs) are considered the final effector cells responsible for producing fine and delicate gastrointestinal (GI) tract movement (Alshboul 2015) . The contractile response of GI smooth muscle is primarily mediated by the phosphorylation of myosin regulatory light chain (MLC20) at Ser19 (Somlyo and Somlyo 2003) , and the degree and duration of contraction depend on the balance between the activity of myosin light chain kinase (MLCK) and myosin light chain phosphatase (MLCP) (Hartshorne, Ito et al. 2004 , Sun, Hu et al. 2015 . Smooth muscle cells generate depolarization when they are stimulated. The intracellular Ca 2+ concentration ([Ca 2+ ]i) is elevated by a Ca 2+ influx from the extracellular space via ion channels, where the most important channels are voltage-operated Ca 2+ channels (VOCCs). The elevation of [Ca 2+ ]i increases the levels of Ca 2+ -bound calmodulin, which then activates MLCK followed by phosphorylating MLC20 at Ser19, resulting in forceful muscle contraction (Somlyo and Somlyo 2003) . This pathway is a classic Ca 2+ -dependent pathway, which plays a predominant role in initiating contraction (Somara, Gilmont et al. 2007 ). However, in addition, membrane depolarization also induces the activation of G-protein-couple receptors, which results in activation of the RhoA/Rho kinase pathway (RhoA/ROCK pathway) and the protein kinase C pathway, which inhibit the activity of MLCP and favours the phosphorylation of MLC20 (Kitazawa, Gaylinn et al. 1991 , Somara, Gilmont et al. 2007 , Alshboul 2015 . In these processes, the smooth muscle forces are enhanced without a change in [Ca 2+ ]i, and this phenomenon is called the Ca 2+ -sensitization pathway (Kitazawa, Gaylinn et al. 1991) . A sustained contractile response has been suggested to be associated with this process.
Pyk2 (proline-rich tyrosine kinase 2) is a nonreceptor tyrosine kinase (Bayer, Heidkamp et al. 2003, Lipinski and Loftus 2010) , which is highly expressed in cells of the haematopoietic lineage and in the central nervous system (Avraham, Park et al. 2000) . Regarding the intracellular distribution, Pyk2 is often enriched in the perinuclear region (Zhang, Qiu et al. 2008) . Various stimuli, including neurotransmitters, bioactive lipids, growth factors, and increased intracellular calcium concentrations, induce Pyk2 phosphorylation. In particular, tyrosine 402 (Tyr-402) is the first residue to be autophosphorylated and represents the initial event in Pyk2 activation; activated Pyk2 then influences multiple signalling pathways, such as the MAP kinase signalling pathway and the Rho kinase pathway (Wu, Jacamo et al. 2006, Lipinski and Loftus 2010) . It has been reported that Pyk2 is phosphorylated at Tyr402 and involved in the contractile response via the RhoA/ROCK signalling pathway in depolarization-induced contraction of vascular smooth muscle cells (VSMCs) (Mills, Mita et al. 2015) . In addition, angiotensin II (Ang II) induces contraction responses of VSMCs by activating the RhoA/ROCK signalling pathway (Rattan, Puri et al. 2003 , Wang, Chen et al. 2015 , and some researchers think that Pyk2 is activated and associated with the RhoA/ROCK signalling pathway in AngII-induced contraction of VSMCs and that the activation of RhoA is reduced when the activity of Pyk2 is inhibited (Ying, Giachini et al. 2009 ). Vascular smooth muscle and GI smooth muscle are both smooth muscle; however, whether
Pyk2 plays a similar role in the contraction of GI smooth muscle has not been reported previously.
Intestinal motility dysfunction conditions are very common, especially in colon. Therefore, in the present study, we hypothesized that the role of Pyk2 during the contraction of colon smooth muscle is the same as in vascular smooth muscle, which is activated by intracellular calcium and related to the contractile response through the RhoA/ROCK signalling pathway.
Here, Pyk2 was shown to be associated with the RhoA/ROCK signalling pathway in the contraction response of colonic smooth muscle, a mechanism that is similar to that seen in vascular smooth muscle.
Materials and methods

Ethics
This study was conducted in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory 
Materials Animals
Adult male ICR mice aged 4 weeks weighing 20-25 g were purchased from the Experimental Animal Center of the Chinese Academy of Sciences, Shanghai, China. The mice were housed at a constant temperature (20-25℃) under a 12 h light/dark cycle, with free access to water and food.
Solutions and Drugs
Tissues were maintained in Krebs solution (mmol/l): NaCl 121.9, NaHCO3 15.5, KCl 5.9, MgSO4 1.2, KH2PO4 1.2, glucose 11.5, and CaCl2 2.5. Tetrodotoxin citrate (TTX), Bay K 8644 and acetylcholine chloride (Ach) were purchased from Tocris
Bioscience. Y-27632, PF-431396, and nifedipine were purchased from Sigma Aldrich (St. Louis, MO, USA).
Methods
Muscle strip preparation and isometric tension measurements
Mice were euthanized by cervical dislocation, and a segment of the colon was immediately removed and placed in aerated (95% O2 and 5% CO2) Krebs solution. Then, after the mesentery was removed with tweezers, the colon was cut open along the mesenteric border and pinned to the base of the Sylgard dish with the mucosa facing upward, and the mucosa and submucosa were removed. The isolated colon muscle strips (2 mm × 8 mm) were longitudinally mounted in an organ bath. A silk thread (USP 5/0) was attached to both ends of the strips. One end of each strip was fixed to the bottom of the muscle chamber, and the other end was attached to an isometric muscle transducer for continuous monitoring of isometric tension. The organ bath was filled with 8 ml of warm (37℃) Krebs solution and bubbled continuously with 95% O2 and 5% CO2. Each mouse muscle strip was placed under a preload of 0 g. The tension energy transducer transmitted the tension signal into the physiological recorder of an RM6280 multi-channel physiological signal acquisition processing system (Instrument Company of Chengdu, Chengdu, China). After the muscle strips were equilibrated in the chamber for 30 min, the dimensional displacement spinner was adjusted to increase the muscular tension to 0.3 g. The experimental drugs were administered when the amplitude and frequency of spontaneous muscle strip contractions were stable.
Colonic smooth muscle cell culture
The colon was opened along the mesenteric border, and the mucosa and submucosa were removed. The layer of colonic smooth muscle was washed with germ-free PBS, cut into several small pieces, placed in a six-well plate containing Dulbecco's Modified Eagle's Medium (DMEM) supplemented with 10% heat-inactivated foetal bovine serum (FBS), 100 U/ml penicillin and 100 mg/ml streptomycin, and cultured in a 37℃ incubator with a 5% CO2 atmosphere. After one week in culture, the cells displayed a triangular or flat-shaped morphology. CSMCs were used between the fourth and six passages for the study. Cells were incubated in serum-free DMEM for 24 h prior to the drug treatments.
Cell lysis and western blotting
Protein samples were extracted from the CSMCs. Cells that had been incubated in the absence or presence of various drugs were washed three times with ice-cold phosphate-buffered saline (PBS), lysed with RIPA buffer (P0013, Beyotime Chemical Co., Jiangsu, China) containing protease inhibitors (P8340, Sigma) and phosphatase inhibitors (P0044, Sigma), and then incubated on ice for 20 min. Cell lysates were centrifuged at 12000 g for 20 min at 4℃. Equivalent amounts of protein (normally 40 µg per lane) were then subjected to 8% or 10% sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) and were detected using an enhanced chemiluminescence reagent (ECL reagent). Band intensities were quantified using Quantity
One software (Bio-Rad, USA).
Statistical analysis
The data are presented as means ± SE. Analysis of differences between multiple groups of data were performed with one-way ANOVA followed by a post hoc Bonferroni test. For comparison between groups, a paired or unpaired Student's t-test was used. Differences were considered significant at P< 0.05.
Results
Role of Pyk2 in the process of spontaneous colonic smooth muscle contraction
The Pyk2 protein was detected by using western blotting and the results showed that Pyk2 was expressed in colonic smooth muscle tissue (Fig 1.A) . GI motility requires the complex coordination of smooth muscles and the enteric nervous system.
Because the purpose of this study was to observe the relationship between Pyk2 and smooth muscle, the influence of the enteric nervous system should be excluded. As a sodium channel blocker, TTX is a drug that is commonly used to block nerve activity.
The amplitudes of spontaneous contractions were obviously decreased after the administration of the Pyk2 inhibitor PF-431396 (Fig 1. Ba) . Moreover, after pretreatment with TTX and PF-431396, the amplitudes of contractions were still decreased (Fig 1. Bb). The PF-431396-induced inhibitory effect was not affected by TTX (Fig 1. Bc) . Similar results were observed when the Rho kinase inhibitor Y-27632 was added; the contractile amplitudes were reduced, regardless of the presence of TTX or not (Fig 1. Ca and Cb). Moreover, a statistically significant difference in the relative change in amplitudes was not observed between the two conditions (Fig 1. Cc) .
Effects of PF-431396 on the protein expression related to the contraction response in cultured CSMCs
Various kinds of interstitial cells are located in the colonic muscular layer, such as ICC and PDGFRα + cells, which directly mediate SMCs contraction. Therefore, the cultured CSMCs were used to rule out the interactions of interstitial cells. The relative levels of intracellular proteins related to the contraction response were detected using western blotting. A significant decrease in the phosphorylation levels of Pyk2 at Tyr402 (Fig 2.A) and MLC20 phosphorylated at Ser19 were observed after cultured CSMCs were treated with PF-431396 (10 μM) for 10 min (Fig 2.B) . However, in the examination of the Ca 2+ -dependent pathway, the MLCK expression level was not affected by PF-431396 (Fig 2.C) . Meanwhile, in the examination of the RhoA/ROCK pathway, PF-431396 significantly inhibited the phosphorylation of MYPT1 at Thr853 (Fig 2.D ) and ROCK2 expression (Fig 2.F) , but not ROCK1 expression (Fig 2.E) . Based on these findings, the role of Pyk2 was more associated with the RhoA/ROCK pathway rather than the Ca 2+ dependent pathway.
Effects of Y-27632 on contraction related protein expression in cultured CSMCs
The ROCK inhibitor Y-27632 was used to further investigate the role of Pyk2 in the RhoA/ROCK pathway. The level of Pyk2 phosphorylated at Tyr402 was weakly but not significantly increased after treatment with Y-27632 (10 μM) for 20 min compared with control (Fig 3.A) , whereas the level of MLC20 phosphorylated at Ser19 was decreased (Fig 3.B) . Meanwhile, in the assessment of the Ca 2+ -dependent pathway, Y-27632 did not significantly change the MLCK expression level (Fig 3.C) .
However, in the examination of the RhoA/ROCK pathway, the expression levels of ROCK1, ROCK2 (Fig 3.D) and MYPT1 phosphorylated at Thr853 (Fig 3.E) were significantly decreased. Based on these findings, the activation of Pyk2 was not affected and phosphorylation of Pyk2 at Tyr402 still occurred after inhibiting the activity of ROCK.
Effects of Ach on contraction related protein expression in cultured CSMCs
Ach is the main excitatory neurotransmitter eliciting GI smooth muscle contraction. Cultured CSMCs were treated with 1 μM Ach for 4 min to investigate whether Pyk2 and colonic smooth muscle contraction have relevant relationships in enhancing contraction responses. Ach induced significant increases in the levels of Pyk2 phosphorylated at Tyr402 (Fig 4.A) and MLC20 phosphorylated at Ser19 (Fig 4.B) , as well as the levels of ROCK2 (Fig 4.C) and MYPT1 phosphorylated at Thr853 (Fig 4.D) in the RhoA/ROCK pathway; however, the ROCK1 expression level was not changed (Fig 4.C) . Based on these results, the activity of Pyk2 is increased during the enhanced contractile response.
Effects of [Ca
2+
]i on the activation of Pyk2
An increase of [Ca 2+ ]i is the primary trigger for the contraction of GI smooth muscles. The most important channel that exerts a substantial influence on [Ca 2+ ]i is the VOCCs (Perrino 2016) . CSMCs were treated with the VOCCs blocker nifedipine (1 μM) or the VOCCs activator Bay K 8644 (1 μM) for 5 min. Nifedipine and Bay K 8644 exert different effects on the phosphorylation of Pyk2 at Tyr402. Bay K 8644, but not nifedipine, significantly increased the levels of Pyk2 phosphorylated at Tyr402 in cultured CSMCs (Fig 3. F) . Thus, elevated [Ca 2+ ]i triggers the phosphorylation of Pyk2 to elicit contraction responses of smooth muscle.
Discussion
In the present experiments, we have examined the relationship between Pyk2 and colonic smooth muscle motility. The main findings of this study are listed below: 1) Pyk2 was expressed in colonic smooth muscle and was activated during colonic smooth muscle contraction; and 2) during the colonic smooth muscle contraction, the activation of Pyk2 occurred prior to activation of the RhoA/ROCK signalling pathway and its involvement in the contraction response was mediated through the RhoA/ROCK pathway.
It has been reported that Pyk2 activation can accelerate the process of differentiation, proliferation and contraction of vascular smooth muscle cells (Ying, Giachini et al. 2009 , Perez, Torres et al. 2011 , Bhattachariya, Turczynska et al. 2014 ).
VSMCs and CSMCs are both smooth muscle cells and the mechanism of contraction response in both is associated with Ca 2+ -dependent and Ca 2+ -sensitization pathways (Kuo and Ehrlich 2015) ; however, few studies have reported the role of Pyk2 in colonic smooth muscle contraction. It is well known that the contraction response in colonic smooth muscle in vitro is spontaneous and is associated with coordination of the enteric nervous system and smooth muscles (Murthy 2006) . However, the spontaneous contraction response continues to happen even after removing the nerves and this phenomenon is associated with the smooth muscle itself, which called myogenic contraction (McCarron, Crichton et al. 1997, de Godoy and Rattan 2011) . In the present study, we found that PF-431396 decreased the contraction response of colonic smooth muscle with or without the presence of TTX indiscriminately (Fig 1) , which showed that Pyk2 can affect the contraction response of colonic smooth muscle and this effect was not related to nerves. In addition, PF-431396 significantly decreased the expression of proteins involved in the RhoA/ROCK signalling pathway, whereas MLCK expression was not affected in the assessment of the Ca 2+ -dependent pathway (Fig 2) . This showed that Pyk2 is more closely associated with the Ca 2+ sensitization pathway than the Ca 2+ dependent pathway.
ROCK has two isoforms, ROCK1 and ROCK2 (Riento and Ridley 2003) , and ROCK2 participates in the contraction response of smooth muscle (Hakoshima, Shimizu et al. 2003 , Nunes, Rigsby et al. 2010 . We found that PF-431396 decreased ROCK2 expression whereas ROCK1 levels were not changed, and Ach increased ROCK2 expression while ROCK1 expression was not altered. However, Y-27632, a non-selective Rho kinase inhibitor, decreased the expression of both ROCK1 and ROCK2
proteins.
Next, the Rho kinase inhibitor Y-27632 was used to further investigate the relationship between the Pyk2 and the RhoA/ROCK pathway. The results showed that Y-27632 decreased the expression of proteins related to the RhoA/ROCK signalling pathway; however, the phosphorylation level of Pyk2 at Tyr402 was not decreased (Fig 3) , which means that Pyk2 activation was not affected by Y-27632. In other words, Pyk2 may act upstream of ROCK. Because Y-27632 is a ROCK inhibitor, it only inhibits the activity of ROCK, thus leading to inhibition of the expression of downstream proteins in the RhoA/ROCK signalling pathway directly or indirectly, while the upstream proteins in the RhoA/ROCK signalling pathway may not be affected in the short term. This is also the reason why we treated CSMCs with drugs for 10 or 20 min because we wanted to observe their current protein changes. In addition, the contraction force was steadily changed at 400 s after using inhibitors in colonic smooth muscle strips in the experiments on isometric tension measurements. Moreover, the phosphorylation level of Pyk2 at Tyr402 was increased when treating CSMCs with Ach and Bay K 8644, a VOCCs opener. These results suggest that the elevation of intracellular Ca 2+ may activate Pyk2 and then activate the RhoA/ROCK signalling pathway and induce smooth muscle contraction.
In addition, it is well known that RhoA plays an important role in the contraction process of smooth muscle, especially in the RhoA/ROCK signalling pathway (Perrino 2016) . The activity of RhoA (GTP-RhoA) is regulated by three types of interacting molecules, guanine nucleotide exchange factors (GEFs), GTPase-activating proteins (GAPs), and guanine nucleotide dissociation inhibitors (GDIs) (Bhattacharyya and Wedegaertner 2003 , Rattan, Puri et al. 2003 , Jin, Ying et al. 2004 . In this study, although a relationship between RhoA and Pyk2 was not detected, there are many reports that have suggested that activation of Pyk2 can promote RhoA activation via RhoGEFs (Lim, Lim et al. 2008 , Ying, Giachini et al. 2009 ), whereas ROCK is the direct downstream effector of RhoA during the contraction process (Alshboul 2015) . By combining the above evidence, we identified a pathway involving Pyk2 and colonic contraction (Fig 5) . Extracellular Ca 2+ entered into CSMCs through VOCCs, causing the activation of Ca 2+ -dependent MLCK and increased MLC20 phosphorylation; at the same time, Pyk2, which is activated by cytosolic Ca 2+ , activates RhoA through RhoGEFs. GTP-RhoA activates ROCK2 to inhibit MLCP activity by phosphorylating MYPT1, which maintains the level of phosphorylated MLC20 and sustains the contraction.
In conclusion, Pyk2 is involved in the process of colonic smooth muscle contraction via the RhoA/ROCK signalling pathway. This mechanism may be a new target for exploring the dysfunction of GI smooth muscle and may provide new insight into researching the GI motility disorders.
